MétaCan
Menu
← Back to cohort
Record W2921163238 · doi:10.1093/jcag/gwz006.090

A91 UNMET NEEDS OF INFLAMMATORY BOWEL DISEASE PATIENTS IN CANADA: RESULTS OF A WEB SURVEY

2019· article· en· W2921163238 on OpenAlexaffabout
J R Gray, Gail Attara, Guy Aumais, Remo Panaccione, John K. Marshall

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2019
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsUniversity of CalgaryUniversité de MontréalCanadian Society of Intestinal ResearchMcMaster University Medical CentreUniversity of British Columbia
Fundersnot available
KeywordsMedicineInflammatory bowel diseaseDiseaseQuality of life (healthcare)Family medicinePopulationUlcerative colitisHealth careInternal medicineNursingEnvironmental health

Abstract

fetched live from OpenAlex

Canada has among the highest prevalences of inflammatory bowel disease (IBD) in the world, at 0.7% of the population. Educational programs are typically aimed at physicians to bridge knowledge gaps. Little is known about the gaps that exist at the patient level. To identify unmet needs in IBD care and knowledge from a patient perspective. The Gastrointestinal Society hosted a survey on its English (www.badgut.org) and French (www.mauxdeventre.org) websites from July 6 to September 4, 2018, asking patients about their views on the unmet needs in IBD. Survey links were posted on social media, boosted via ads. To qualify, survey participants had to be living in Canada and have moderate to severe IBD. Questions included a variety of topics on IBD, such as medication, health care, and day-to-day life. Four hundred and thirty-two IBD patients (81% female) responded from all provinces (56% Crohn’s disease, 42% ulcerative colitis, 7% other). When asked their ultimate goal in treating IBD, aside from finding a cure, responses included maintaining a good quality of life (36%) and achieving remission (32%). Common concerns regarding flares of disease included losing the ability to function daily (63%), pain (58%), impact on work (33%) or family (25%), and needing surgery (22%). When asked which tools offered by their gastroenterologist were most useful to them, 60% said tests and monitoring, 54% medication selection and monitoring, 39% information on treatment options, 34% explanation of treatment goals, and 29% discussions on quality of life. 56% of respondents claimed that medications currently available only somewhat control their IBD and 20% said that they do not control symptoms. 43% of respondents were concerned about the risks of surgery. 63% of respondents were somewhat concerned, concerned, or very concerned about non-medical switching from an innovator biologic to a biosimilar, and 89% were somewhat to very concerned that there were fewer biologic options for IBD than for other immune-mediated inflammatory diseases. Respondents were interested in learning more about other aspects of treatment, including diet (57%), medical cannabis (48%), and increasing support from their health care team (39%). Canadians with IBD believe their symptoms are not under control much of the time. They worry about the impact of disease flares on their day-to-day lives and want more support from their health care team. Many individuals want to learn more about how diet and medical cannabis might help. The Gastrointestinal Society received a grant from Janssen Canada.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.030
Threshold uncertainty score0.215

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0020.005
Science and technology studies0.0030.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.003
GPT teacher head0.181
Teacher spread0.178 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of Gastroenterology→Same topicInflammatory Bowel Disease→French-language works237,207→